Search results summary

From Health Canada

Search criteria

  • Status: Select all
  • AIG: 0102420001

Search results

List of returned drug products
Products returned by the search are listed, including their status, DIN number, name, class, total count of active ingredients and the name of one, etc. Clicking on the value in the DIN column returns more complete information about the related product.
Status DIN Company Product Class PM See footnote1 Schedule # See footnote2 A.I. name See footnote3 Strength
Marketed 00402737 APOTEX INC APO-OXAZEPAM Human Yes Targeted (CDSA IV) 1 OXAZEPAM 30 MG
Cancelled Post Market 02247179 BIOMED PHARMA BIO-OXAZEPAM Human No Targeted (CDSA IV) 1 OXAZEPAM 30 MG
Cancelled Post Market 00496537 NOVOPHARM LIMITED NOVOXAPAM TAB 30MG Human No Targeted (CDSA IV) 1 OXAZEPAM 30 MG
Cancelled Pre Market 02232732 LABORATOIRES CONFAB INC OXAZEPAM 30MG TABLETS Human No Targeted (CDSA IV) 1 OXAZEPAM 30 MG / TAB
Cancelled Post Market 00483907 D.C. LABS LIMITED OXAZEPAM TABLETS 30MG Human No Targeted (CDSA IV) 1 OXAZEPAM 30 MG
Dormant 00414263 BIOMED PHARMA OXPAM Human Yes Targeted (CDSA IV) 1 OXAZEPAM 30 MG
Cancelled Post Market 00726389 PHARMASCIENCE INC PMS-OXAZEPAM TAB 30MG Human No Targeted (CDSA IV) 1 OXAZEPAM 30 MG
Marketed 00497770 PRO DOC LIMITEE PRO-OXAZEPAM Human Yes Targeted (CDSA IV) 1 OXAZEPAM 30 MG
Marketed 00568414 LABORATOIRE RIVA INC. RIVA-OXAZEPAM Human Yes Targeted (CDSA IV) 1 OXAZEPAM 30 MG
Cancelled Post Market 00231363 WYETH LTD. SERAX TAB 30MG Human No Targeted (CDSA IV) 1 OXAZEPAM 30 MG / TAB
Cancelled Post Market 02043688 WYETH-AYERST CANADA INC. SERAX TABLETS 30MG Human No Targeted (CDSA IV) 1 OXAZEPAM 30 MG / TAB
Version 4.0.2
Date modified: